Results from the PEARLS/KEYNOTE-091 study, a triple-blind phase 3 trial, have...
The CheckMate 816 study has demonstrated that neoadjuvant nivolumab +...
Individuals diagnosed with oligometastatic NSCLC can benefit from local...
Divya Natesan from the University of Pittsburgh sought to examine the frequency...
Prof Dr Cora Sternberg shared her findings from the SAUL study. This study...
Prof Miriam Koopman presented the findings of the CAIRO-4 study. This study,...
Dr Benedikt Westphalen addressed the question of whether both irinotecan and...
Dr Floris Verheij presented the long-term results of the OPRA trial. The OPRA...
The NeoRhea study is a phase 2 clinical trial that focuses on patients with...
Genomic signatures have shown promise in predicting the pathological complete...